市場調査レポート

商品コード

1494821

埋め込み型バイオマテリアルの2030年までの市場予測：材料別、用途別、エンドユーザー別、地域別の世界分析

Implantable Biomaterials Market Forecasts to 2030 - Global Analysis By Material (Natural Biomaterials, Ceramics and Composites), Application (Ophthalmology, Plastic Surgery and Other Applications), End User and By Geography

出版日: 2024年06月06日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 600,256円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 759,360円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 918,464円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,084,800円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.64円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、埋め込み型バイオマテリアルの世界市場は2024年に1,121億6,000万米ドルを占め、予測期間中のCAGRは14.7％で成長し、2030年には2,553億9,000万米ドルに達すると予測されています。

埋め込み型バイオマテリアルは、治療デリバリーシステムから組織置換まで、医療目的で体内に埋め込むように設計された物質です。有害性や拒絶反応を起こすことなく、生体システムと相互作用するように設計されています。これらの物質には合成のものと天然のものがあり、その特性は生体適合性、機械的強度、分解速度など、特定の用途に合わせて調整されます。

米国を拠点とする国立公衆衛生機関である疾病対策予防センターによると、米国では20歳以上の成人の20人に1人が心血管疾患を患っています。

老人人口の増加

老年人口の増加は、いくつかの要因から埋め込み型バイオマテリアル市場の重要な促進要因となっています。第一に、高齢になるにつれて、人工関節置換術、歯科インプラント、心血管インプラントなど、生体材料に依存する医療介入が必要になる可能性が高くなります。第二に、高齢者は骨粗鬆症や心血管系疾患のような加齢に関連した疾患を経験することが多く、治療やサポートにバイオマテリアルを使用する必要があります。さらに、ヘルスケアの進歩は平均寿命の延長につながり、埋め込み型バイオマテリアルの需要をさらに高めています。

生体材料ベースの製品の限界

生体材料ベースの製品は移植可能な医療機器を大きく進歩させたが、限界がないわけではないです。重要な制約のひとつは、これらの材料に対する患者の反応のばらつきにあり、免疫反応や組織拒絶反応を引き起こす可能性があります。さらに、生体材料の経時的劣化は、器具の完全性と機能性を損なう可能性があり、頻繁な交換や修正が必要となります。生体材料をベースとしたインプラントの開発・製造に関連するコストは、もう一つの大きな障壁であり、しばしば患者にとっては高価格につながります。

インプラント生体材料に対する有利な償還金

埋め込み型バイオマテリアルに対する有利な償還は、埋め込み型バイオマテリアル市場に大きな機会をもたらしています。ヘルスケアシステムがこれらの材料に関連する費用を負担するようになってきているため、患者はより高度で耐久性のあるソリューションに傾倒しています。これが需要と採用を促進し、市場の成長を後押ししています。また、有利な払い戻しは、ヘルスケアプロバイダーがこうした革新的なソリューションを提供するインセンティブとなり、市場をさらに拡大します。さらに、この分野の研究開発が促進され、より効果的で汎用性の高い生体材料のイントロダクションつながっています。このような動向は市場拡大のための環境を整え、患者と業界の利害関係者の双方に利益をもたらします。

患者にとっての甚大な災害や個人的不幸

埋め込み型バイオマテリアル市場では、材料拒絶反応、インプラントの不具合、感染症などの要因により、患者にとって甚大な災害や個人的な不幸が生じる可能性があります。材料拒絶は、身体の免疫系が移植された材料に否定的な反応を示すことで起こり、合併症や潜在的な健康リスクにつながります。インプラントの不具合は、機械的な問題や周囲の組織との不適切な統合が原因で起こることがあり、追加の手術や介入が必要になります。移植中あるいは移植後の感染症は、患者の健康状態に深刻な脅威をもたらし、全身的な合併症を引き起こす可能性があります。

COVID-19の影響：

COVID-19の流行は、埋め込み型バイオマテリアル市場に大きな影響を与えています。埋め込み型生体材料を必要とする手術を含む選択的手術は、ヘルスケア資源の再配分と安全性への懸念から延期または中止されました。このため、そうした材料の需要が減少しました。さらに、世界のサプライチェーンと製造プロセスの混乱が、これらの生体材料の入手可能性に影響を与えました。しかし、ヘルスケアシステムが適応し、選択的処置が再開されるにつれて、市場は徐々に回復すると予想されます。さらに、ヘルスケア・インフラの回復力とバイオマテリアル・テクノロジーの革新に重点が置かれるようになることで、市場の将来的な成長が促進される可能性があります。

予測期間中、金属および金属合金セグメントが最大になる見込み

埋め込み型バイオマテリアル市場における金属および金属合金セグメントは、いくつかの要因によって大きな成長を遂げています。チタンやその合金のような金属は、その優れた生体適合性、耐食性、機械的特性により、関節置換や歯科インプラントのようなインプラントに理想的な材料として支持されています。加えて、冶金学の進歩は、性能の向上と特性に合わせた新しい合金の開発につながり、このセグメントの成長をさらに促進しています。整形外科疾患や歯科疾患の有病率の増加と、インプラントを求める高齢化も、このセグメントの拡大に寄与しています。

整形外科分野は予測期間中に最も高いCAGRが見込まれる

埋め込み型バイオマテリアル市場の整形外科分野は、近年大きな成長を遂げています。この成長はいくつかの要因によるものです。生体材料技術の進歩により、整形外科用インプラントに適した耐久性と生体適合性の高い材料が開発され、患者の予後を改善し、再手術の必要性を減らしています。さらに、世界の高齢化が関節置換術や脊椎手術などの整形外科手術の増加に寄与し、埋め込み型バイオマテリアルの需要を押し上げています。さらに、これらのインプラントの利点に関する患者やヘルスケア提供者の意識の高まりが、市場の拡大に拍車をかけています。

最大のシェアを占める地域

近年、北米は埋め込み型生体材料市場で顕著な成長を遂げています。この急成長は、医療技術の進歩、ヘルスケア支出の増加、高齢化人口の増加など、いくつかの要因によるものです。加えて、慢性疾患や筋骨格系疾患の有病率が上昇していることも、同地域全体の埋め込み型生体材料の需要を促進しています。さらに、主な市場プレイヤーの存在と活発な研究開発活動が市場拡大をさらに刺激しています。規制当局の支援と有利な償還政策も、北米の市場成長を促進する上で重要な役割を果たしています。

CAGRが最も高い地域：

アジア太平洋地域は、いくつかの要因によって埋め込み型バイオマテリアル市場で著しい成長を遂げています。ヘルスケア支出の増加、慢性疾患の有病率の増加、高齢化人口の増加が、埋め込み型医療機器の需要を促進しています。さらに、生体材料技術や手術技術の進歩が市場拡大を後押ししています。中国、ヘルスケア、日本のような国々は、医療インフラの改善と医療ツーリズムの急増に後押しされ、成長軌道をリードしています。加えて、有利な政府の取り組みと支援的な規制の枠組みが、この地域への投資を促し、成長をさらに促進しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品発売
事業拡大
その他の主要戦略

第10章企業プロファイリング

3M
Arthrex
BASF SE
Bayer AG
Berkeley Advanced Biomaterials
Biomet
Cam Bioceramics B.V.
Carpenter Technology Corporation
Celanese Corporation
CeramTec
Collagen Solutions Plc
CoorsTek Inc.
DuPont
Evonik Industries AG
Linden Lab
Medtronic
Royal DSM
Stryker Corporation
Zimmer Biomet Holdings

図表

List of Tables

Table 1 Global Implantable Biomaterials Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
Table 3 Global Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
Table 4 Global Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
Table 5 Global Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
Table 6 Global Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
Table 7 Global Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
Table 8 Global Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
Table 9 Global Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
Table 10 Global Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
Table 11 Global Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
Table 12 Global Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
Table 13 Global Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
Table 14 Global Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
Table 15 Global Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
Table 16 Global Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
Table 17 Global Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
Table 18 Global Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
Table 19 Global Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 20 Global Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
Table 21 North America Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
Table 22 North America Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
Table 23 North America Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
Table 24 North America Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
Table 25 North America Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
Table 26 North America Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
Table 27 North America Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
Table 28 North America Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
Table 29 North America Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
Table 30 North America Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
Table 31 North America Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
Table 32 North America Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
Table 33 North America Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
Table 34 North America Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
Table 35 North America Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
Table 36 North America Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
Table 37 North America Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
Table 38 North America Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
Table 39 North America Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 40 North America Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
Table 41 Europe Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
Table 42 Europe Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
Table 43 Europe Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
Table 44 Europe Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
Table 45 Europe Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
Table 46 Europe Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
Table 47 Europe Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
Table 48 Europe Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
Table 49 Europe Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
Table 50 Europe Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
Table 51 Europe Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
Table 52 Europe Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
Table 53 Europe Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
Table 54 Europe Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
Table 55 Europe Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
Table 56 Europe Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
Table 57 Europe Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
Table 58 Europe Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
Table 59 Europe Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 60 Europe Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
Table 61 Asia Pacific Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
Table 62 Asia Pacific Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
Table 63 Asia Pacific Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
Table 64 Asia Pacific Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
Table 65 Asia Pacific Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
Table 66 Asia Pacific Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
Table 67 Asia Pacific Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
Table 68 Asia Pacific Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
Table 69 Asia Pacific Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
Table 70 Asia Pacific Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
Table 71 Asia Pacific Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
Table 72 Asia Pacific Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
Table 73 Asia Pacific Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
Table 74 Asia Pacific Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
Table 75 Asia Pacific Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
Table 76 Asia Pacific Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
Table 77 Asia Pacific Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
Table 78 Asia Pacific Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
Table 79 Asia Pacific Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 80 Asia Pacific Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
Table 81 South America Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
Table 82 South America Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
Table 83 South America Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
Table 84 South America Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
Table 85 South America Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
Table 86 South America Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
Table 87 South America Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
Table 88 South America Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
Table 89 South America Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
Table 90 South America Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
Table 91 South America Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
Table 92 South America Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
Table 93 South America Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
Table 94 South America Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
Table 95 South America Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
Table 96 South America Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
Table 97 South America Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
Table 98 South America Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
Table 99 South America Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 100 South America Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
Table 101 Middle East & Africa Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
Table 102 Middle East & Africa Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
Table 103 Middle East & Africa Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
Table 104 Middle East & Africa Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
Table 105 Middle East & Africa Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
Table 106 Middle East & Africa Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
Table 107 Middle East & Africa Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
Table 108 Middle East & Africa Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
Table 109 Middle East & Africa Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
Table 110 Middle East & Africa Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
Table 111 Middle East & Africa Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
Table 112 Middle East & Africa Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
Table 113 Middle East & Africa Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
Table 114 Middle East & Africa Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
Table 115 Middle East & Africa Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
Table 116 Middle East & Africa Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
Table 117 Middle East & Africa Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
Table 118 Middle East & Africa Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
Table 119 Middle East & Africa Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
Table 120 Middle East & Africa Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)

Product Code: SMRC26337

According to Stratistics MRC, the Global Implantable Biomaterials Market is accounted for $112.16 billion in 2024 and is expected to reach $255.39 billion by 2030 growing at a CAGR of 14.7% during the forecast period. Implantable biomaterials are substances designed to be placed inside the body for medical purposes, ranging from therapeutic delivery systems to tissue replacement. They are engineered to interact with biological systems without causing harm or rejection. These materials can be synthetic or natural, and their properties are tailored to specific applications, such as biocompatibility, mechanical strength, and degradation rate.

According to the Centers for Disease Control and Prevention, a US-based national public health agency, in the US, 1 in 20 adults age 20 and older have cardiovascular diseases.

Market Dynamics:

Driver:

The increase in the geriatric population

The rise in the geriatric population is a significant driver for the implantable biomaterials market due to several factors. Firstly, as people age, there's a greater likelihood of needing medical interventions such as joint replacements, dental implants, and cardiovascular implants, all of which rely on biomaterials. Secondly, older individuals often experience age-related conditions like osteoporosis or cardiovascular diseases, necessitating the use of biomaterials for treatment or support. Additionally, advancements in healthcare have led to increased life expectancy, further contributing to the demand for implantable biomaterials.

Restraint:

Limitations of biomaterial-based products

While biomaterial-based products have significantly advanced implantable medical devices, they are not without limitations. One key restraint lies in the variability of patient responses to these materials, leading to potential immune reactions or tissue rejection. Moreover, biomaterial degradation over time can compromise the device's integrity and functionality, necessitating frequent replacements or revisions. The cost associated with developing and manufacturing biomaterial-based implants is another significant barrier, often leading to higher prices for patients.

Opportunity:

Favorable reimbursements for implantable biomaterials

Favorable reimbursements for implantable biomaterials present a significant opportunity in the implantable biomaterials market. With healthcare systems increasingly covering the costs associated with these materials, patients are more inclined towards advanced and durable solutions. This drives demand and adoption, boosting market growth. Favorable reimbursements also incentivize healthcare providers to offer these innovative solutions, further expanding the market. Moreover, it encourages research and development in the field, leading to the introduction of more effective and versatile biomaterials. This trend creates a conducive environment for market expansion, benefiting both patients and industry stakeholders.

Threat:

Huge disasters or personal misfortunes for the patient

In the implantable biomaterials market, huge disasters or personal misfortunes for patients could arise from factors such as material rejection, implant failure, or infection. Material rejection occurs when the body's immune system reacts negatively to the implanted material, leading to complications and potential health risks. Implant failure can result from mechanical issues or improper integration with surrounding tissues, necessitating additional surgeries or interventions. Infections, either during or after implantation can pose serious threats to the patients' health condition and can lead to systemic complications.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the implantable biomaterials market. Elective surgeries, including those requiring implantable biomaterials, were postponed or cancelled due to healthcare resource reallocation and safety concerns. This led to a decline in demand for such materials. Additionally, disruptions in the global supply chain and manufacturing processes affected the availability of these biomaterials. However, as healthcare systems adapt and elective procedures resume, the market is expected to gradually recover. Furthermore, increased emphasis on healthcare infrastructure resilience and innovation in biomaterial technologies may drive future growth in the market.

The metals and metal alloys segment is expected to be the largest during the forecast period

The metals and metal alloys segment in the implantable biomaterials market has experienced significant growth due to several factors. Metals like titanium and its alloys are favored for their excellent biocompatibility, corrosion resistance, and mechanical properties, making them ideal for implants such as joint replacements and dental implants. Additionally, advancements in metallurgy have led to the development of new alloys with improved performance and tailored properties, further driving the segment's growth. The increasing prevalence of orthopedic and dental disorders, coupled with an aging population seeking implants, has also contributed to the expansion of this segment.

The Orthopaedics segment is expected to have the highest CAGR during the forecast period

The orthopaedics segment within the implantable biomaterials market has experienced significant growth in recent years. This growth can be attributed to several factors. Advancements in biomaterial technology have led to the development of more durable and biocompatible materials suitable for orthopaedic implants, enhancing patient outcomes and reducing the need for revision surgeries. Additionally, an aging population worldwide has contributed to the rise in orthopaedic procedures, such as joint replacements and spinal surgeries, driving demand for implantable biomaterials. Moreover, increasing awareness among patients and healthcare providers about the benefits of these implants has fueled market expansion.

Region with largest share:

In recent years, North America has experienced notable growth in the implantable biomaterials market. This surge can be attributed to several factors, including advancements in medical technology, increased healthcare expenditure, and a growing aging population. Additionally, the rising prevalence of chronic diseases and musculoskeletal disorders has fuelled the demand for implantable biomaterials across the region. Moreover, the presence of key market players and robust research and development activities has further stimulated market expansion. Regulatory support and favourable reimbursement policies have also played a significant role in fostering market growth in North America.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth in the implantable biomaterials market due to several factors. Rising healthcare expenditures, an increasing prevalence of chronic diseases, and a growing aging population are driving the demand for implantable medical devices. Moreover, advancements in biomaterial technology and surgical techniques have bolstered market expansion. Countries like China, India, and Japan are leading the growth trajectory, propelled by improving healthcare infrastructure and a surge in medical tourism. Additionally, favorable government initiatives and supportive regulatory frameworks have encouraged market players to invest in the region, further fueling growth.

Key players in the market

Some of the key players in Implantable Biomaterials market include 3M, Arthrex, BASF SE, Bayer AG, Berkeley Advanced Biomaterials, Biomet, Cam Bioceramics B.V., Carpenter Technology Corporation, Celanese Corporation, CeramTec, Collagen Solutions Plc, CoorsTek Inc., DuPont, Evonik Industries AG, Linden Lab, Medtronic, Royal DSM, Stryker Corporation and Zimmer Biomet Holdings.

Key Developments:

In May 2024, Zimmer Biomet Holdings, Inc., a global medical technology leader, announced the successful completion of the world's first robotic-assisted shoulder replacement surgery using its ROSA Shoulder System. The surgery was performed at Mayo Clinic by John W. Sperling, MD, MBA, Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota, and a key contributor to the ROSA Shoulder development team.

In May 2024, Arecor and Medtronic say they partnered to create a new type of insulin that would allow for the use of new insulin pump designs. These new insulin pumps in mind would sit under the skin, rather than on the surface of the skin. The research collaboration aims to develop a novel, high-concentration, thermostable insulin for use by Medtronic in a next-generation pump. A new insulin of this kind could minimize the need for pump maintenance interventions and expand utility for physicians while saving costs.

Materials Covered:

Natural Biomaterials
Ceramics
Metals and Metal Alloys
Synthetic Polymers
Composites

Applications Covered:

Ophthalmology
Plastic Surgery
Wound Healing
Cardiology
Dental
Orthopedics
Other Applications

End Users Covered:

Specialty Clinics
Hospitals
Ambulatory Surgical Centers
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Implantable Biomaterials Market, By Material

5.1 Introduction
5.2 Natural Biomaterials
5.3 Ceramics
5.4 Metals and Metal Alloys
5.5 Synthetic Polymers
5.6 Composites

6 Global Implantable Biomaterials Market, By Application

6.1 Introduction
6.2 Ophthalmology
6.3 Plastic Surgery
6.4 Wound Healing
6.5 Cardiology
6.6 Dental
6.7 Orthopedics
6.8 Other Applications

7 Global Implantable Biomaterials Market, By End User

7.1 Introduction
7.2 Specialty Clinics
7.3 Hospitals
7.4 Ambulatory Surgical Centers
7.5 Other End Users

8 Global Implantable Biomaterials Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 3M
10.2 Arthrex
10.3 BASF SE
10.4 Bayer AG
10.5 Berkeley Advanced Biomaterials
10.6 Biomet
10.7 Cam Bioceramics B.V.
10.8 Carpenter Technology Corporation
10.9 Celanese Corporation
10.10 CeramTec
10.11 Collagen Solutions Plc
10.12 CoorsTek Inc.
10.13 DuPont
10.14 Evonik Industries AG
10.15 Linden Lab
10.16 Medtronic
10.17 Royal DSM
10.18 Stryker Corporation
10.19 Zimmer Biomet Holdings

埋め込み型バイオマテリアルの2030年までの市場予測：材料別、用途別、エンドユーザー別、地域別の世界分析

Implantable Biomaterials Market Forecasts to 2030 - Global Analysis By Material (Natural Biomaterials, Ceramics and Composites), Application (Ophthalmology, Plastic Surgery and Other Applications), End User and By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の埋め込み型バイオマテリアル市場：材料別

第6章 世界の埋め込み型バイオマテリアル市場：用途別

第7章 世界の埋め込み型バイオマテリアル市場：エンドユーザー別

第8章 世界の埋め込み型バイオマテリアル市場：地域別

第9章 主な発展

第10章 企業プロファイリング